259 related articles for article (PubMed ID: 24038081)
41. Inhibitory effect of the small heterodimer partner on hepatocyte nuclear factor-4 mediates bile acid-induced repression of the human angiotensinogen gene.
Shimamoto Y; Ishida J; Yamagata K; Saito T; Kato H; Matsuoka T; Hirota K; Daitoku H; Nangaku M; Yamagata K; Fujii H; Takeda J; Fukamizu A
J Biol Chem; 2004 Feb; 279(9):7770-6. PubMed ID: 14672953
[TBL] [Abstract][Full Text] [Related]
42. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
43. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
[TBL] [Abstract][Full Text] [Related]
44. Hairy and enhancer of split 6 prevents hepatic lipid accumulation through inhibition of
Park JE; Lee M; Kim SC; Zhang Y; Hardwick JP; Lee YK
Hepatol Commun; 2017 Dec; 1(10):1085-1098. PubMed ID: 29404444
[TBL] [Abstract][Full Text] [Related]
45. Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1α.
Xu L; Huang Z; Lo TH; Lee JTH; Yang R; Yan X; Ye D; Xu A; Wong CM
Theranostics; 2022; 12(6):2502-2518. PubMed ID: 35401831
[No Abstract] [Full Text] [Related]
46. Liraglutide ameliorates hepatic steatosis via retinoic acid receptor-related orphan receptor α-mediated autophagy pathway.
Yu X; Bian X; Zhang H; Yang S; Cui D; Su Z
IUBMB Life; 2023 Oct; 75(10):856-867. PubMed ID: 37310057
[TBL] [Abstract][Full Text] [Related]
47. Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A.
Kim YC; Seok S; Zhang Y; Ma J; Kong B; Guo G; Kemper B; Kemper JK
Nat Commun; 2020 Nov; 11(1):5969. PubMed ID: 33235221
[TBL] [Abstract][Full Text] [Related]
48. The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice.
Myronovych A; Salazar-Gonzalez RM; Ryan KK; Miles L; Zhang W; Jha P; Wang L; Setchell KD; Seeley RJ; Kohli R
Obesity (Silver Spring); 2014 Nov; 22(11):2301-11. PubMed ID: 25376397
[TBL] [Abstract][Full Text] [Related]
49. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
50. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
51. Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator-Activated Receptor γ in Mice.
Tong J; Han CJ; Zhang JZ; He WZ; Zhao GJ; Cheng X; Zhang L; Deng KQ; Liu Y; Fan HF; Tian S; Cai J; Huang Z; She ZG; Zhang P; Li H
Hepatology; 2019 Jun; 69(6):2471-2488. PubMed ID: 30748020
[TBL] [Abstract][Full Text] [Related]
52. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions.
Abu-Elheiga L; Wu H; Gu Z; Bressler R; Wakil SJ
J Biol Chem; 2012 Apr; 287(15):12578-88. PubMed ID: 22362781
[TBL] [Abstract][Full Text] [Related]
53. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
[TBL] [Abstract][Full Text] [Related]
54. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
[TBL] [Abstract][Full Text] [Related]
55. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
[TBL] [Abstract][Full Text] [Related]
56. E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1/SHP/EID1 network.
Zhang Y; Xu N; Xu J; Kong B; Copple B; Guo GL; Wang L
Hepatology; 2014 Sep; 60(3):919-30. PubMed ID: 24619556
[TBL] [Abstract][Full Text] [Related]
57. Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist.
Xu J; Christian B; Jump DB
J Biol Chem; 2006 Jul; 281(27):18351-62. PubMed ID: 16644726
[TBL] [Abstract][Full Text] [Related]
58. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
59. Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation.
Park CH; Kim JH; Lee EB; Hur W; Kwon OJ; Park HJ; Yoon SK
PLoS One; 2017; 12(1):e0169685. PubMed ID: 28081181
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma.
Mukhopadhyay B; Liu J; Osei-Hyiaman D; Godlewski G; Mukhopadhyay P; Wang L; Jeong WI; Gao B; Duester G; Mackie K; Kojima S; Kunos G
J Biol Chem; 2010 Jun; 285(25):19002-11. PubMed ID: 20410309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
